AU591466B2 - Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body - Google Patents

Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body

Info

Publication number
AU591466B2
AU591466B2 AU48936/85A AU4893685A AU591466B2 AU 591466 B2 AU591466 B2 AU 591466B2 AU 48936/85 A AU48936/85 A AU 48936/85A AU 4893685 A AU4893685 A AU 4893685A AU 591466 B2 AU591466 B2 AU 591466B2
Authority
AU
Australia
Prior art keywords
tumors
delivering
chemotherapeutic agents
particles encapsulating
micellular particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU48936/85A
Other versions
AU4893685A (en
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Raymond Leo Teplitz
George Wing-Yiu Tin
Lawrence Ernest Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
City of Hope National Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/663,550 external-priority patent/US5441745A/en
Priority claimed from US06/663,503 external-priority patent/US5435989A/en
Application filed by City of Hope National Medical Center filed Critical City of Hope National Medical Center
Publication of AU4893685A publication Critical patent/AU4893685A/en
Application granted granted Critical
Publication of AU591466B2 publication Critical patent/AU591466B2/en
Assigned to VESTAR, INC. reassignment VESTAR, INC. Alteration of Name(s) in Register under S187 Assignors: CITY OF HOPE NATIONAL MEDICAL CENTER
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU48936/85A 1984-10-22 1985-10-22 Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body Expired AU591466B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US663550 1984-10-22
US06/663,550 US5441745A (en) 1982-03-30 1984-10-22 Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US06/663,503 US5435989A (en) 1982-03-30 1984-10-22 Method of targeting a specific location in a body
US67420184A 1984-11-23 1984-11-23
US674201 1984-11-23
US663503 1996-06-14

Related Child Applications (2)

Application Number Title Priority Date Filing Date
AU14540/88A Division AU615184B2 (en) 1984-10-22 1988-04-12 Method of targeting tumors in humans
AU51143/90A Division AU5114390A (en) 1984-10-22 1990-03-07 Method of targeting tumors in humans

Publications (2)

Publication Number Publication Date
AU4893685A AU4893685A (en) 1986-05-01
AU591466B2 true AU591466B2 (en) 1989-12-07

Family

ID=27418087

Family Applications (3)

Application Number Title Priority Date Filing Date
AU48936/85A Expired AU591466B2 (en) 1984-10-22 1985-10-22 Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
AU14540/88A Expired AU615184B2 (en) 1984-10-22 1988-04-12 Method of targeting tumors in humans
AU51143/90A Abandoned AU5114390A (en) 1984-10-22 1990-03-07 Method of targeting tumors in humans

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU14540/88A Expired AU615184B2 (en) 1984-10-22 1988-04-12 Method of targeting tumors in humans
AU51143/90A Abandoned AU5114390A (en) 1984-10-22 1990-03-07 Method of targeting tumors in humans

Country Status (1)

Country Link
AU (3) AU591466B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
AU1519683A (en) * 1982-03-29 1983-10-24 Liposome Company, Inc., The Stable plurilamellar vesicles
AU560178B2 (en) * 1983-09-26 1987-04-02 Udo Ehrenfeld Liposomes as carrier for immune modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
AU1519683A (en) * 1982-03-29 1983-10-24 Liposome Company, Inc., The Stable plurilamellar vesicles
AU560178B2 (en) * 1983-09-26 1987-04-02 Udo Ehrenfeld Liposomes as carrier for immune modulators

Also Published As

Publication number Publication date
AU4893685A (en) 1986-05-01
AU1454088A (en) 1988-07-21
AU615184B2 (en) 1991-09-26
AU5114390A (en) 1990-07-05

Similar Documents

Publication Publication Date Title
HK1007494A1 (en) Encapsulation of antineoplastic agents in liposomes
CS729486A2 (en) Method of particles production with effective substance's controlled loosening
AU587825B2 (en) LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
AU4902985A (en) Magnetically responsive particles and method of preparation
EP0203768A3 (en) A therapeutic effervescent composition and a method of preparing the same
GR3002279T3 (en) Reduction of dysfunction in angioplasty procedures
JPS6448882A (en) Abrasive particle and abrasive
AU574346B2 (en) Micellular particle labelled leukocytes and phagocytic cells
EP0179557A3 (en) Improvements in or relating to magnetic powder compacts
AU591158B2 (en) Titanates in the form of spherical particles and process for preparing same
IL82240A0 (en) Method and arrangement for determining a nuclear magnetization distribution in a part of a body
GB2206206B (en) Reversible aggregation of particles
AU591466B2 (en) Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
DE3479479D1 (en) Vitamin composition with enhanced bioavailability and method of administering same
EP0303588A3 (en) Method of particle size determination
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
ZA855476B (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
GB8630396D0 (en) Winning etc of minerals present in seam
GB8925527D0 (en) Fertilizer particle and method of preparation
GB2179080B (en) Suspension of powders in liquid for soil injection and the like
IL71470A0 (en) Novel galenic forms of sulpirid suitable for oral administration and their preparation
GB8501351D0 (en) Preparation of spongy metallic body
NZ213848A (en) Electrical connector and connector terminal: retention of terminal in connector body
GB2169817B (en) Method of dispersing short fibres in metallic powders
IL75399A0 (en) High-density antacid powder and method for the preparation thereof